These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 26891864)

  • 21. The human gene for alkaptonuria (AKU) maps to chromosome 3q.
    Janocha S; Wolz W; Srsen S; Srsnova K; Montagutelli X; Guénet JL; Grimm T; Kress W; Müller CR
    Genomics; 1994 Jan; 19(1):5-8. PubMed ID: 8188241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alkaptonuria: a very rare metabolic disorder.
    Aquaron R
    Indian J Biochem Biophys; 2013 Oct; 50(5):339-44. PubMed ID: 24772955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alkaptonuria: From Molecular Insights to a Dedicated Digital Platform.
    Milella MS; Geminiani M; Trezza A; Visibelli A; Braconi D; Santucci A
    Cells; 2024 Jun; 13(12):. PubMed ID: 38920699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alkaptonuria and intramedullary calcification.
    Raina S; Mahesh DM; Kaushal SS; Gupta D; Dhiman DS; Negi A; Sharma S
    J Assoc Physicians India; 2008 Jul; 56():552-5. PubMed ID: 18846913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A role for interleukins in ochronosis in a chondrocyte in vitro model of alkaptonuria.
    Mistry JB; Jackson DJ; Bukhari M; Taylor AM
    Clin Rheumatol; 2016 Jul; 35(7):1849-56. PubMed ID: 26474772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new integrated and interactive tool applicable to inborn errors of metabolism: Application to alkaptonuria.
    Spiga O; Cicaloni V; Zatkova A; Millucci L; Bernardini G; Bernini A; Marzocchi B; Bianchini M; Zugarini A; Rossi A; Zazzeri M; Trezza A; Frediani B; Ranganath L; Braconi D; Santucci A
    Comput Biol Med; 2018 Dec; 103():1-7. PubMed ID: 30316064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of antioxidant drugs for the treatment of ochronotic alkaptonuria in an in vitro human cell model.
    Tinti L; Spreafico A; Braconi D; Millucci L; Bernardini G; Chellini F; Cavallo G; Selvi E; Galeazzi M; Marcolongo R; Gallagher JA; Santucci A
    J Cell Physiol; 2010 Oct; 225(1):84-91. PubMed ID: 20648626
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biochemical and proteomic characterization of alkaptonuric chondrocytes.
    Braconi D; Bernardini G; Bianchini C; Laschi M; Millucci L; Amato L; Tinti L; Serchi T; Chellini F; Spreafico A; Santucci A
    J Cell Physiol; 2012 Sep; 227(9):3333-43. PubMed ID: 22213341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Knee ochronotic arthropathy and arthroscopic findings].
    Kural C; Cetinus EM; Kural A; Uğraş AA; Kaya I
    Acta Orthop Traumatol Turc; 2009; 43(1):67-71. PubMed ID: 19293619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of Melanin-like Pigment Synthesized from Homogentisic Acid, with or without Tyrosine, and Its Implications in Alkaptonuria.
    Taylor AM; Vercruysse KP
    JIMD Rep; 2017; 35():79-85. PubMed ID: 27943071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unrecognized ochronosis--a case report.
    Murgić L; Grubisić F; Jajić Z
    Acta Clin Croat; 2008 Jun; 47(2):105-9. PubMed ID: 18949907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alkaptonuria: Current Perspectives.
    Zatkova A; Ranganath L; Kadasi L
    Appl Clin Genet; 2020; 13():37-47. PubMed ID: 32158253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amyloidosis in alkaptonuria.
    Millucci L; Braconi D; Bernardini G; Lupetti P; Rovensky J; Ranganath L; Santucci A
    J Inherit Metab Dis; 2015 Sep; 38(5):797-805. PubMed ID: 25868666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alkaptonuria.
    Mistry JB; Bukhari M; Taylor AM
    Rare Dis; 2013; 1():e27475. PubMed ID: 25003018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Redox proteomics gives insights into the role of oxidative stress in alkaptonuria.
    Braconi D; Millucci L; Ghezzi L; Santucci A
    Expert Rev Proteomics; 2013 Dec; 10(6):521-35. PubMed ID: 24206226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Biomechanical studies on the pathogenesis of ochronotic arthropathy].
    Eberle P; Mohr W; Claes L
    Z Rheumatol; 1984; 43(5):249-52. PubMed ID: 6524111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Homogentisic acid induces cytoskeleton and extracellular matrix alteration in alkaptonuric cartilage.
    Galderisi S; Cicaloni V; Milella MS; Millucci L; Geminiani M; Salvini L; Tinti L; Tinti C; Vieira OV; Alves LS; Crevenna AH; Spiga O; Santucci A
    J Cell Physiol; 2021 Aug; 236(8):6011-6024. PubMed ID: 33469937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nitisinone Arrests but Does Not Reverse Ochronosis in Alkaptonuric Mice.
    Keenan CM; Preston AJ; Sutherland H; Wilson PJ; Psarelli EE; Cox TF; Ranganath LR; Jarvis JC; Gallagher JA
    JIMD Rep; 2015; 24():45-50. PubMed ID: 25940034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative proteomics in alkaptonuria provides insights into inflammation and oxidative stress.
    Braconi D; Bernardini G; Paffetti A; Millucci L; Geminiani M; Laschi M; Frediani B; Marzocchi B; Santucci A
    Int J Biochem Cell Biol; 2016 Dec; 81(Pt B):271-280. PubMed ID: 27590860
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.